Troutman Pepper Counsels Pharma Nobis Investment Group in Acquisition of Fagron’s Contract Manufacturing Business and Manufacturing Facility
NEW YORK – Troutman Pepper advised an investment consortium Pharma Nobis, LLC – which includes Signet Healthcare Partners, Bionpharma, Inc, and GMS Capital Partners LLC – in its planned acquisition of Fagron’s U.S. contract manufacturing business. This business unit, operating from a manufacturing facility in Texarkana, Texas, provides contract manufacturing and private label services for consumer healthcare companies and retailers in the United States. Read a company press release about the transaction.
Signet Healthcare Partners is an established private equity firm that provides growth capital to innovative, commercial-stage healthcare companies. GMS Capital Partners LLC is an investment management firm focused on sourcing, arranging and making investments across different asset classes, including private equity, venture capital, real estate and other alternative asset classes. Bionpharma is a vibrant and fast growing generic pharmaceutical company with a strong commercial portfolio and a pipeline of generic products in the United States.
Partners Andrew Hulsh and Joe Kadlec led a Troutman Pepper team that served as legal counsel for the acquiring syndicate.
Consistently recognized as a top-tier national practice, Troutman Pepper’s corporate attorneys regularly handle multimillion- and multibillion-dollar transactions. Core areas of service include capital markets transactions and other significant domestic and cross-border transactions, mergers and acquisitions, corporate governance, securities laws compliance, and corporate finance. The firm has particular expertise in the private equity and private fund services space, advising leading private equity firms on a broad range of matters, including fund formation, growth equity investments and buyouts, and exit transactions.
About Troutman Pepper
Troutman Pepper is a national law firm with more than 1,200 attorneys strategically located in 23 U.S. cities. The firm’s litigation, transactional, and regulatory practices advise a
diverse client base, from start-ups to multinational enterprises. The firm provides sophisticated legal solutions to clients’ most pressing business challenges, with depth across industry sectors, including construction, energy,
financial services, health sciences, insurance, private equity, and real estate, among others. Learn more at
troutman.com.